Regimen snapshot
A structured overview of the products included in the report.
Coming soon · waitlist only
The full-regimen interaction checker is coming.
The Regimen Safety Report is being built to review prescriptions, supplements, GLP-1s, peptides, hormone therapy, and regulated cannabinoids together.
For now, join the waitlist and follow inPhormacist Notes while the report workflow, privacy boundaries, and review standards are finalized.
Waitlist only while the product is built
No payment, account, or detailed regimen intake is live yet. Early access is currently limited to lightweight interest capture through inPhormacist Notes.
Join Early AccessPrelaunch capture stays intentionally light until the detailed intake flow is ready.
Planned report scope
Built for the full regimen, not only drug-drug pairs.
Prescription and OTC medications
Supplements and herbals
GLP-1s and emerging peptides
Hormone therapy
Lawfully obtained medical cannabis and regulated cannabinoids
Live now
Early access, research notes, and the public education hub.
In buildout
The full-regimen checker, report structure, and reviewed public records.
Later
Detailed intake, account features, payment flow, and recurring report options after policy review.
Sample report preview
What the report is being designed to include
This is a product preview, not a live report and not a request for health information.
Interaction themes
Source-backed patterns that may deserve clinician discussion.
Evidence context
Evidence level, confidence, source count, and uncertainty notes.
Discussion points
Educational questions to bring to a licensed clinician.
Not live yet
The paid report workflow is still in buildout and review.
Educational framing
Outputs will be designed for discussion with a licensed clinician.
Review gate
The same careful review standards will shape public and report content.